Black Diamond Therapeutics Inc

NASDAQ:BDTX   4:00:00 PM EDT
1.71
-0.15 (-8.06%)
5:22:52 PM EDT: $1.70 -0.01 (-0.59%)
Earnings Announcements

Black Diamond Therapeutics Reports Third Quarter Results

Published: 11/08/2022 13:25 GMT
Black Diamond Therapeutics Inc (BDTX) - Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.